Literature DB >> 3115480

Endogenous digoxin-like immunoreactivity in congestive heart failure.

L Shilo1, A Adawi, G Solomon, L Shenkman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115480      PMCID: PMC1247275          DOI: 10.1136/bmj.295.6595.415-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Endogenous digitalis-like substance in plasma of volume-expanded dogs.

Authors:  K A Gruber; J M Whitaker; V M Buckalew
Journal:  Nature       Date:  1980-10-23       Impact factor: 49.962

2.  Lowering of blood pressure in chronic aortic coarctate hypertensive rats with anti-digoxin antiserum.

Authors:  C T Huang; R M Smith
Journal:  Life Sci       Date:  1984-07-02       Impact factor: 5.037

3.  Protein binding of endogenous digoxin-immunoactive factors in human serum and its variation with clinical condition.

Authors:  R Valdes; S W Graves
Journal:  J Clin Endocrinol Metab       Date:  1985-06       Impact factor: 5.958

4.  Natriuretic hormone - a circulating inhibitor of sodium- and potassium-activated adenosine triphosphatase. Its potential role in body fluid and blood pressure regulation.

Authors:  H J Kramer
Journal:  Klin Wochenschr       Date:  1981-11-16
  4 in total
  3 in total

Review 1.  Endogenous factors with immunological and biological activity similar to cardiac glycosides: biochemical and pathophysiological implications.

Authors:  A Clerico; G Mariani
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

2.  Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.

Authors:  R G Morris; D B Frewin; N C Saccoia; W L Goldsworthy; W S Jeffries; A J McPhee
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Total digoxin-like immunoreactive factor(s) in healthy population, uncomplicated term pregnancies and neonates.

Authors:  N Krivoy; P Jakobi; E Paldi; G Alroy
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.